Plasmodium falciparum Nicotinamidase as A Novel Antimalarial Target
Sign Up to like & getrecommendations! Published in 2022 at "Biomolecules"
DOI: 10.3390/biom12081109
Abstract: Inhibition of Plasmodium falciparum nicotinamidase could represent a potential antimalarial since parasites require nicotinic acid to successfully recycle nicotinamide to NAD+, and importantly, humans lack this biosynthetic enzyme. Recently, mechanism-based inhibitors of nicotinamidase have been… read more here.
Keywords: plasmodium falciparum; nicotinamidase novel; nicotinamidase; novel antimalarial ... See more keywords